Jean-Baptiste Pinaquy

Dr. Jean-Baptiste Pinaquy


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2014 in The Prostate
Verified
Journal Article
Closed access
PDF file
JPJean-Baptiste Pinaquy
Jean-Baptiste Pinaquy
HCHenri De Clermont‐Galleran
Henri De Clermont‐Galleran
GPGilles Pasticier
Gilles Pasticier
GRGerald Rigou
Gerald Rigou
NANicolas Alberti
Nicolas Alberti
PFPhilippe Fernandez
Philippe Fernandez

9 March 2017 in Journal of Nuclear Medicine
Verified
Journal Article
Open access
PDF file
CHClémence Houard
Clémence Houard
JPJean-Baptiste Pinaquy
Jean-Baptiste Pinaquy
CMCharles Mesguich
Charles Mesguich
BFBénédicte Henriques de Figueiredo
Bénédicte Henriques de Figueiredo
ACAnne-Laure Cazeau
Anne-Laure Cazeau
VVVéronique Vendrely
Véronique Vendrely
The aim of this study was to evaluate the relevance of positron emission tomography/computed tomography and 18F-fluorodeoxyglucose (FDG-PET/CT) as a strategy for response evaluation after chemoradiotherapy for anal cancer. For this, the performance of post-treatment FDG-PET/CT, the impact on patient care and the predictive value of metabolic response were assessed. Methods: This was a retrospective and multicenter analysis of 87 patients treated by chemoradiotherapy for anal squamous cell carcinoma between October 2007 and October 2013. All patients underwent systematic post-treatment FDG-PET/CT and were followed with at least a clinical examination every 4 months for 2 years, and every 6 months thereafter. Disease progression was confirmed by biopsy for all patients in case of local recurrence before surgery. Kaplan-Meier and Cox regression models were used to test for associations between metabolic or clinical endpoints and progression-free survival (PFS) or cause-specific survival (CSS). Results: Median follow-up was 25 months. FDG-PET/CT was performed 1 to 8 months (median 4 months) after completion of chemoradiotherapy. Overall, 25 patients relapsed and 13 died. The post-therapy FDG-PET/CT did not show any abnormal 18F-FDG uptake (complete metabolic response: CMR) in 55 patients whereas 32 displayed incomplete response (non-CMR): 15 patients with partial response and 17 with disease progression. Sensitivity of FDG-PET/CT for the determination of CMR was 92% (95% CI: 75-97%), specificity was 85% (95% CI: 75-92%), positive predictive value was 72% (95% CI: 61-90%), and negative predictive value was 96.4 % (95% CI: 90-98.7%). The 2-year PFS was 96% for patients with CMR, and 28% for non-CMR patients (p<0.0001; 95 % CI:16.4-47.1). The 2-year CSS was 100% for patients with CMR and 59% for those without CMR (p<0.0001; 95 % CI: 10.1-31.1). FDG- PET/CT changed patient management in 14 cases (16%) with relevant modifications in 12 (14%). A Cox proportional hazards model of survival outcome indicated that a CMR was the only significant predictor of PFS and CSS (p<0.0001). Conclusion: FDG-PET/CT shows good accuracy in post-treatment evaluation of anal cancer and has a relevant impact on patient management. Moreover, CMR is associated with good survival outcome. Thus FDG-PET/CT may play a significant role during post-treatment follow-up of anal cancer

1 October 2018 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
MPMathilde Puges
Mathilde Puges
SPSabine Pereyre
Sabine Pereyre
XBXavier Bérard
Xavier Bérard
IAIsabelle Accoceberry
Isabelle Accoceberry
CRChloé Le Roy
Chloé Le Roy
CCCharles Cazanave
Charles Cazanave

1 April 2015 in Clinical Nuclear Medicine
Verified
Journal Article
Closed access
JPJean-Baptiste Pinaquy
Jean-Baptiste Pinaquy
PFPhilippe Fernandez
Philippe Fernandez
GPGilles Pasticier
Gilles Pasticier
MPMarie Parrens
Marie Parrens
HCHenri De Clermont
Henri De Clermont
A 62-year-old patient with prostate adenocarcinoma underwent PET with radiolabeled choline (18F-Fcholine) for pretreatment staging of a high-risk prostate cancer. Images showed a significant mediastinal lymph node uptake of 18F-Fcholine. Owing to the rarity of spread to supradiaphragmatic lymph nodes, a surgical removal was performed, revealing anthracosis and no malignant cells. Even if its specificity seems better than 18F-FDG, false positives have been reported and other pathologies could mimic lymph node metastases. Consequently, histology should be performed so that the appropriate treatment can be initiated.

1 August 2019 in Infection and Drug Resistance
Verified
Journal Article
Open access
MPMathilde Puges
Mathilde Puges
AMArmelle Ménard
Armelle Ménard
XBXavier Berard
Xavier Berard
MGMagalie Geneviève
Magalie Geneviève
JPJean-Baptiste Pinaquy
Jean-Baptiste Pinaquy
CCCharles Cazanave
Charles Cazanave
Bartonella alsatica is a wild rabbit pathogen causing bacteremia rarely reported in humans, with only three cases published so far, including one lymphadenitis and two endocarditis cases. Here, we report the case of a 66-year-old man who suffered from acute renal failure due to a membranoproliferative glomerulonephritis. Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) showed diffuse FDG uptake around the aortobifemoral graft with no indication of infection. A white blood cell scan showed an accumulation of labeled neutrophils on the left femoral part of the graft. The patient underwent surgery and an abscess around the left iliac part of the graft was found intraoperatively. Intraoperative samples were all negative, but 16S rRNA gene-based PCR was positive, and the sequence was positioned among the Bartonella species cluster. Specific PCRs targeting groEL/hsp60, rpoB and gltA genes were performed and led to the identification of B. alsatica. Accordingly, indirect immunofluorescence serological analyses were positive for Bartonella henselae and Bartonella quintana. The patient had a history of regularly hunting wild rabbits. He was treated with 100 mg of doxycycline twice a day for six months and his renal function significantly improved with no sign of persistent infection. This case highlights the contribution of serology assays and molecular-based methods in prosthetic vascular graft infection diagnosis.

1 June 2021 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
MDMaïlys Ducours
Maïlys Ducours
JLJulie Leitao
Julie Leitao
MPMathilde Puges
Mathilde Puges
SPSabine Pereyre
Sabine Pereyre
FGFrédéric Gabriel
Frédéric Gabriel
CCCharles Cazanave
Charles Cazanave
We describe the fourth cases of arterial aneurysm consecutive to Capnocytophaga canimorsus infection in a 77-year-old man. The infection occurred after a dog bite. He presented fever. The thoracic-abdominal computed tomography angiography revealed aneurysms on the abdominal aorta, left common femoral artery, and left popliteal artery. The diagnosis was performed by a blood culture positive for Capnocytophaga canimorsus. The outcome was favorable with surgery and antibiotic therapy.